Msd In The Uk company information, Employees & Contact Information

MSD calls off £1bn UK expansion amid government-big pharma tensions Pharmaceutical Technology

Reaction to MSD's UK exit as government tries to renew talks pharmaphorum

Merck scraps £1bn expansion in the UK over lack of state investment BBC

Big pharma firms have paused nearly £2bn in UK investments this year | Pharmaceuticals industry The Guardian

Merck slams UK as it scraps £1bn London drug research centre Financial Times

Drugmaker Wants £46M For MSD's Use Of 'Merck' In UK Law360

Innovation, the Pathway, and the Patient: Shaping the Future of UK Cancer Care in 2025 National Health Executive

UK court dismisses appeal in Merck v Merck dispute The Global Legal Post

Fresh blow to UK life sciences as MSD abandons £1bn project pharmaphorum

Big pharma will stop investing in UK, top scientist warns after Merck’s £1bn exit | Pharmaceuticals industry The Guardian

Has Britain got what it needed from Donald Trump? politicsuk.com

UK ‘must act’ to stem life science losses, says Patrick Vallance Research Professional News

Arsenal Women and Beth Mead to use North London derby with Spurs to raise further awareness of MSD UK campaign to help eliminate cervical cancer Sky Sports

UK accountancy firm buys Dublin-based MSD in foray into market The Irish Times

MSD’s sotatercept gains UK MHRA approval Pharmaceutical Technology

Deliberate by default? RSM UK

Is UK pharma really ‘uninvestable’? Chemistry World

MSD gives warning to UK ahead of $1.3bn facility work pharmaphorum

MSD’s David Peacock on moving UK healthcare forward pharmaphorum

US-Based MSD Must Pay £6M For Use Of 'Merck' In UK Law360

MSD reveals the first details of its job cut plans pharmaphorum

Ben Lucas - MSD - Board Member Association of the British Pharmaceutical Industry (ABPI)

Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales Yahoo Finance

UK set on resolving standoff with big pharma, science minister says | Pharmaceuticals industry The Guardian

AZ halts UK investment, and Lilly, Sanofi follow suit pharmaphorum

Novo Nordisk, MSD restructure amid tariff, European policy pressures 조선일보

US drugmaker Merck scraps £1bn London research centre and cuts 125 science jobs The Guardian

Merck to open £1bn London research centre with plea for government support of industry Financial Times

New laboratory space for MSD at The Francis Crick Institute PharmaTimes

NICE gives green light for MSD’s Keytruda PharmaTimes

Bringing the power of multidisciplinary research to neurodegeneration Nature

MSD selects London site for US$1.32bn research complex The Chemical Engineer

In another round of Merck vs. Merck, Germany-based Merck KGaA notches a win in the U.K. Fierce Pharma

Sign of the times: why English clubs are turning to high-interest US loans | David Conn The Guardian

Finadyne 50 mg/ml Solution for Injection - Product defect recall alert GOV.UK

David Peacock is new UK managing director for MSD PharmaTimes

MSD launches once-daily Isentress in the UK PharmaTimes

MSD launches antibiotic combo Recarbrio in UK PMLiVE

New managing director joins MSD UK PharmaTimes

Merck plans to build £1bn UK research hub in central London Financial Times

Major pharma leader MSD first to endorse government’s Industrial Strategy as it announces major investment in the UK GOV.UK

MSDUK: Challenges, risks and real opportunities for a truly inclusive supply chain Supply Chain Digital

MSD to Leave the London's Francis Crick Institute' Skylab as part of UK R&D Wind Down PharmiWeb.com

MSD launches Clostridium difficile antitoxin in the UK PharmaTimes

MSD appoints Jessica Fine as UK external affairs director PMLiVE

MSD launches EU’s first biosimilar Herceptin in UK PMLiVE

MSD UK appoints Jessica Fine as executive director of external affairs Pharmafile

Partners Nuffield Trust

I love my job because... Pf Media

Dr Fiona Marshall heads up MSD’s new UK research facility PMLiVE

Ben Lucas appointed new MD of MSD, UK and Ireland Pf Media

Ulcerative colitis control: an interview with Dr Paul Robinson, Medical Director, MSD UK News-Medical

Merck v Merck: a lesson on the practical implications of co-existence agreements and online use in the digital age CMS LAW-NOW

Unilever and Google back MSDUK supplier diversity initiative Global Cosmetics News

Early diagnosis and timely treatment: Why both are key to improving cancer survival Politics Home

Drug gives patients with rare tumour-causing disease hope at last The Times

MSDUK announces the finalists for this year’s Innovation challenge My Startup World

MSD appoints new UK head PMLiVE

MSD announce David Peacock as new Managing Director in UK and Ireland Pharmafile

pladis joins MSDUK group to improve supply chain workforce diversity Confectionery Production

High beef prices at risk as BRD looms over youngstock FarmingUK